Cargando…
The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis
BACKGROUND: The role of the pulmonary microbiome in sarcoidosis is unknown. The objectives of this study were the following: (1) examine whether the pulmonary fungal and bacterial microbiota differed in patients with sarcoidosis compared with controls; (2) examine whether there was an association be...
Autores principales: | Knudsen, Kristel S., Lehmann, Sverre, Nielsen, Rune, Tangedal, Solveig, Paytuvi-Gallart, Andreu, Sanseverino, Walter, Martinsen, Einar M. H., Hiemstra, Pieter S., Eagan, Tomas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580159/ https://www.ncbi.nlm.nih.gov/pubmed/36258251 http://dx.doi.org/10.1186/s40168-022-01362-4 |
Ejemplares similares
-
The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease
por: Knudsen, Kristel S., et al.
Publicado: (2022) -
A longitudinal study of the pulmonary mycobiome in subjects with and without chronic obstructive pulmonary disease
por: Martinsen, Einar M. H., et al.
Publicado: (2022) -
The pulmonary mycobiome—A study of subjects with and without chronic obstructive pulmonary disease
por: Martinsen, Einar M. H., et al.
Publicado: (2021) -
The airway microbiota and exacerbations of COPD
por: Leiten, Elise Orvedal, et al.
Publicado: (2020) -
Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients
por: Tangedal, Solveig, et al.
Publicado: (2019)